FDA recall D-0051-2025

Tailstorm Health INC · Class II · drug

Product

BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Healthcare: 24416 N 19th Ave, Phoenix, AZ, NDC 81483-0041-1

Reason for recall

Lack of Sterility Assurance

Distribution

Nationwide Within U.S.

Key facts

Status: Terminated
Initiation date: 2024-11-06
Report date: 2024-11-27
Termination date: 2025-03-28
Voluntary/Mandated: Voluntary: Firm initiated
Location: Phoenix, AZ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0051-2025